RxDoctor Payments Data

Shaina Saufley

Acute Care · North Chesterfield, VANPI 1760875538

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 382 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,103in general payments, 2019–2025

Across 382 payments — averaging $18.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$1K
  • Johnson & Johnson$1K
  • Novartis$612
  • Mallinckrodt Hospital Products Inc.$542
  • UCB, Inc.$511
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$7,06399%
  • Education$401%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,103 in reported general payments places this provider in the 95th percentile of 599 acute care providers in Virginia.

See all acute care providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept33$316,481
Humira PenAdalimumab15$190,316
Orencia ClickjectAbatacept23$131,956
ActemraTocilizumab11$59,981
KevzaraSarilumab11$46,322
Actemra ActpenTocilizumab17$42,020
TymlosAbaloparatide12$31,077
MethotrexateMethotrexate Sodium320$9,175
Leflunomide97$6,104
Hydroxychloroquine Sulfate164$5,674
Pregabalin97$4,380
Gabapentin115$3,020
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen99$2,170
Tramadol Hcl165$2,018
Prednisone341$1,924

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
SanofiKevzara$39$46,32211 claims
Radius Health, Inc.Tymlos$97$31,07712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 599 acute care providers in Virginia.

Other acute care in North Chesterfield

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →